Hepatitis B vaccination after living donor liver transplantation
Yuji Soejima(Shinshu University), Yoshihiko Maehara(Kyushu University), Tomoharu Yoshizumi(Kyushu University), Toru Ikegami(Jikei University School of Medicine), Yo‐ichi Yamashita(Kumamoto University), Akinobu Taketomi(Hokkaido University), Noboru Harada(Kyushu University), Hideaki Uchiyama(Kyushu University)
Cited by 36
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244